anatomy
Genetic Disorders
Srujana Rayalam DVM, PhD
Dept. of Pharmaceutical Sciences
PCOM-GA campus
PHAR 113G Anatomy, Physiology & Pathophysiology I
8/26/2020 10:31 AM
© 2007 Microsoft Corporation. All rights reserved. Microsoft, Windows, Windows Vista and other product names are or may be registered trademarks and/or trademarks in the U.S. and/or other countries.
The information herein is for informational purposes only and represents the current view of Microsoft Corporation as of the date of this presentation. Because Microsoft must respond to changing market conditions, it should not be interpreted to be a commitment on the part of Microsoft, and Microsoft cannot guarantee the accuracy of any information provided after the date of this presentation. MICROSOFT MAKES NO WARRANTIES, EXPRESS, IMPLIED OR STATUTORY, AS TO THE INFORMATION IN THIS PRESENTATION.
1
Learning Objectives
Describe the mutation responsible for sickle cell anemia and understand the genetic inheritance pattern
State how newborn screening can limit the incidence of phenylketonuria
Describe the key features of genetic disorders: cystic fibrosis and Marfan syndrome
Explain how mutations in col1a1 gene cause different types of osteogenesis imperfecta and how a dominant negative effect can arise
Explain the inheritance pattern for mutations in hemophilia
Describe how expansion of trinucleotide repeats contributes to genetic disorders
Outline how multifactorial genetic disorders arise
Explain aneuploidy associated with Down syndrome
Explain how inheritance patterns for mitochondrial & nuclear DNA differ
Types of Inheritance Patterns
Single gene inheritance
Not very common
Types of patterns: Autosomal Dominant; Autosomal Recessive; X-linked Dominant and X-linked Recessive
Recessive inheritance is typical of mutations in enzymes – 50% normal enzyme usually enough
Dominant inheritance is typical of mutations in structural protein – 50% normal amount of protein is not enough
Multifactorial inheritance
Mitochondrial inheritance
Chromosome abnormalities
Sickle Cell Anemia
Autosomal recessive inheritance pattern
Homozygous HbS (HbSS) is called sickle cell anemia (SCA)
Normal hemoglobin - two α chains and two β chains.
The biochemical defect that leads to the development of HbS involves the substitution of valine for glutamic acid as the sixth amino acid in the β-polypeptide chain.
RBC life span – reduced from normal 120 to ~10 days resulting in the inability of bone marrow to catch-up with the loss
Hemolysis – free hemoglobin inactivated NO causing vasoconstriction
Sickle Cell Anemia
1 in 10 carrier in African American population
Hypoxia triggers polymerization of Hb
Certain endemic areas in Africa – sickling of RBC protection against malaria
Other mutations on Hb gene (no sickling)
HbC: Glutamic acid replaced by lysine
Thalassemia: Defects in either alpha or beta chains of Hb – abnormal Hb resulting in anemia
Thalassemia major (homozygous for mutated allele)
Thalassemia minor (carrier/heterozygous)
Sickle cell gene inheritance scheme
(Example)
Pathophysiology
Robbins & Cotran Pathologic Basis of Disease (8th edition)
Pathophysiology
Phenylketonuria (PKU)
Characterized by abnormal phenylalanine metabolism → hyperphenylalaninemia
Autosomal recessive condition
Bi-allelic mutations of the gene encoding the enzyme phenylalanine hydroxylase (PAH)
PAH converts phenylalanine → tyrosine
PAH deficiency → accumulation of phenylalanine and its breakdown chemicals in the blood and body tissues
Phenylketonuria (PKU)
Excess phenylalanine or its metabolites contribute to the brain damage in PKU.
Affected infants are normal at birth but within a few weeks develop a rising plasma phenylalanine level → impairs brain development.
Excess phenylalanine is converted into phenylpyruvate (also known as phenylketone), which is detected in the urine.
A normal blood phenylalanine level is about 1mg/dl.
In cases of PKU, levels may range from 6-80mg/dl, but are usually greater than 30mg/dl.
Phenylketonuria (PKU)
Phenylalanine is an essential amino acid and is found in nearly all foods which contain protein, dairy products, nuts, beans, tofu… etc.
A low protein diet must be followed.
Individuals with PKU must be alert for food sweetened with aspartame.
Every state now screens the blood phenylalanine level of all newborns at about 3 days of age.
This test is one of several newborn screening tests performed before or soon after discharge from the hospital.
PKU- Inheritance Pattern
http://www.health.state.mn.us/divs/fh/mcshn/ncfu/cond/pku.htm
Cystic Fibrosis
A chronic, progressive, and frequently fatal genetic disease of the body’s mucus glands.
Primary defect due to abnormal function of an epithelial chloride channel protein encoded by the cystic fibrosis transmembrane conductance regulator (CFTR) gene on chromosome 7.
Although autosomal recessive, even heterozygote carriers have a higher incidence of respiratory and pancreatic diseases.
Ion transport disturbances in epithelial cells affects fluid secretion in exocrine glands and the epithelial lining of the respiratory, gastrointestinal, and reproductive tracts.
Common among Caucasians (especially Europeans), 1 in 20 are carriers.
Cystic Fibrosis
Mucoviscidosis
Mucus in CF patients is very thick and accumulates in the intestines and lungs.
The result is malnutrition, poor growth, frequent respiratory infections, breathing difficulties, and eventually permanent lung damage.
Lung disease is the usual cause of death in most patients.
Difficulty in breathing, pancreatic infections, sinus infection, cirrhosis of liver and infertility
Pathophysiology
CFTR regulates multiple additional ion channels and cellular processes.
The functions of CFTR are tissue-specific
sweat ducts, loss of CFTR function leads to ↓reabsorption of sodium chloride and production of hypertonic sweat
In respiratory epithelium, CFTR mutations result in loss or reduction of chloride secretion into the lumen
Various mutations grouped based on their effect on the CFTR protein
Robbins & Cotran Pathologic Basis of Disease (8th edition)
Clinical manifestations of mutations in the cystic fibrosis gene
Robbins & Cotran Pathologic Basis of Disease (8th edition)
Marfan Syndrome
Is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder.
Disorder of connective tissues, manifested principally by changes in the skeleton, eyes, and cardiovascular system.
Missense mutations in the FBN1 gene give rise to abnormal fibrillin-1, the major component of microfibrils found in the extracellular matrix.
Skeletal abnormalities are the most striking feature - unusually tall with exceptionally long extremities and long, tapering fingers and toes.
Osteogenesis Imperfecta
Due to variety of mutations in genes encoding subunits of type I collagen
Collagen
Most abundant protein in the body
Synthesized from fibroblasts
Type 1 collagen comprises 80% of total collagen in skin and muscle tissue
Composed of 2 chains of α1(I) collagen & 1 chain of α2(I) collagen that form a triple helix
Types I, II, III and V, and XI - fibrillar collagens
Type IV – basement membrane collagen
Types of Collagen
| FIBRILLAR COLLAGENS | |
| I | Ubiquitous in hard and soft tissues |
| II | Cartilage, intervertebral disk, vitreous |
| III | Hollow organs, soft tissues |
| V | Soft tissues, blood vessels |
| BASEMENT MEMBRANE COLLAGENS | |
| IV | Basement membranes |
Type I collagen is the only form of collagen in bone
Formation of Triple Helix in Collagen
Pathophysiology of Disease: an Introduction to Clinical Medicine (6th edition)
Triple-helical fibers comprise 2 chains of α1 & 1 chain of α2 collagen
Molecular pathogenesis of type I osteogenesis imperfecta
Presence of normal proα1(I) allele allows 50% reduced production of collagen
Disease phenotype relatively mild: Short stature, postnatal fractures, blue sclera, premature hearing loss
Dominant pattern of inheritance – 50% of normal type I collagen insufficient
Mutations in type I OI prevent expression of proα1(I) chain
Molecular pathogenesis of type II osteogenesis imperfecta
Collagen molecule has impaired function even with one normal proα1(I) chain - “Dominant negative” effect
Disease phenotype worse than type I osteogenesis imperfecta
Severe prenatal fractures & bone deformities, connective tissue fragility
Expression of defective protein worse than no expression from mutant allele
Mutations in type II OI cause defect in proα1(I) chain
Hemophilia
Hemophilia is the oldest known hereditary bleeding disorder.
Caused by a recessive gene on the X chromosome.
There are about 20,000 hemophilia patients in the United States.
One can bleed to death with small cuts.
The severity of hemophilia is related to the amount of the clotting factor in the blood. About 70% of hemophilia patients have less than one percent of the normal amount and, thus, have severe hemophilia.
Hemophilia
Hemophilia A
Royal diseases/Bleeding disease
Defective clotting factor VIII
More common
Hemophilia B
Christmas disease
Defective clotting factor IX
Less common
Hemophilia Genetic Inheritance
Fragile X-Associated Mental Retardation Syndrome
Second most common genetic cause of mental retardation
Inherited in X-linked dominant fashion
Caused by excessive number of CGG repeats in 5’-untranslated region of fmr1 gene
Number of trinucleotide (CGG) repeats varies (6–55) in normal individuals
A repeat size between 60 and 200 does not cause a clinical phenotype but is unstable and subject to additional amplification
Extensive expansion occurs during oogenesis (not during spermatogenesis)
Excessive number of repeats (>200) prevents transcription of fmr1 gene
Robbins & Cotran Pathologic Basis of Disease (8th edition)
Penetrance & expressivity tend to increase in successive generations due to expansion of trinucleotide repeats
Genetic Anticipation in Fragile X-Associated Mental Retardation Syndrome
Multifactorial Inheritance
Very common - many factors, both genetic and environmental are involved
Typically involve more common genetic variations called polymorphisms
Most are “single-nucleotide polymorphisms” – SNPs
Cause modest change in function (or expression) of particular protein
Do not cause overt disease, but modestly increase risk of disease
Examples of multifactorial traits and diseases include: height, neural tube defects, cancer, diabetes, asthma, coronary artery disease, hip dysplasia etc
Down Syndrome
Most common cause of mental retardation
Occurs in about 1 in 700 newborns in the USA
Two major genetic abnormalities associated with Down syndrome:
Nondisjunction of chromosome 21 during meiotic segregation, resulting in one extra chromosome 21 (trisomy 21), with 47 chromosomes on karyotyping.
Mostly involves extra maternal copy of chromosome 21
DNA rearrangement resulting in the fusion of chromosome 21 to another acrocentric chromosome via its centromere. This abnormal chromosome is called a robertsonian translocation chromosome. Unlike those with trisomy 21, these individuals have 46 chromosomes on karyotyping.
Prevalence increases with increasing age of mother
Relationship of Down syndrome to maternal age
Pathophysiology of Disease: an Introduction to Clinical Medicine (6th edition)
Amniocentesis data
Live births
Down Syndrome
Common features include developmental delay, growth restriction, congenital heart disease (in 50%), immunodeficiency, and characteristic major and minor facial and dysmorphic phenotypic features
Trisomy 21 causes 50% increase in the expression of many proteins encoded by chromosome 21
Unclear why this causes symptoms of Down syndrome
May be due to clusters of multiple genes in same biological pathway
Mitochondrial DNA
Each cell contains thousands of mitochondria, each containing copies of its DNA
Mitochondrial DNA is in larger quantities in a cell
Nuclear DNA is larger in size
Mitochondrial DNA is inherited from mother
Maternal Inheritance Pattern with Mitochondrial DNA
Summary
Sickle cell anemia
Phenylketonuria
Cystic fibrosis and Marfan syndrome
Osteogenesis imperfecta; dominant negative effect
Hemophilia
Expansion of trinucleotide repeats – genetic anticipation
Mitochondrial inheritance
Aneuploidy associated with Down syndrome
Multifactorial genetic disorders